Reimbursed with a limitationGenericATC L01BC07

Azacitidin Ideogen

Azacitidin Ideogen is a generic from Ideogen AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 223.75 to CHF 223.75 depending on the pack; the co-payment is 10 per cent.

Core data

Authorisation holder
Ideogen AG
ATC code
L01BC07
IT group
07.16.10 Cytostatica
Active substances
Azacitidinum
Preparation type
Generic
On the SL since
01/04/2022
Last price change
01/04/2022
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Azacitidin Ideogen Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Trockensub 100 mgDurchstf 1 StkCHF 189.00CHF 223.7501/04/2022A7680679660014

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingIndication 21414.02Valid from 01/04/2022

Behandlung von Patienten, die für eine Transplantation hämatopoetischer Stammzellen nicht geeignet sind und eines der folgenden Krankheitsbilder aufweisen:
- Myelodysplastisches Syndrom mit intermediärem oder hohem Risiko gemäss International Prognostic Scoring System (IPSS) vom Typ refraktäre Zytopenie mit multilineärer Dysplasie (RCMD) oder refraktäre Anämie mit 5-19% Knochenmarksblasten (RAEB I und II)
- Chronisch myelomonozytäre Leukämie
- Akute myeloische Leukämie (AML) mit 20-30% Knochenmarksblasten und Mehrlinien-Dysplasie (gemäss Klassifikation der World Health Organisation (WHO) 2008)
- Akute myeloische Leukämie (AML) mit >30% Knochenmarksblasten, gemäss Klassifikation der WHO, bei älteren Patienten, die für eine intensive Chemotherapie nicht geeignet sind oder diese nicht vertragen.

More preparations in this group

FAQ

Is Azacitidin Ideogen covered by Swiss health insurance?

Yes, but only under conditions. Azacitidin Ideogen is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Azacitidin Ideogen cost in Switzerland?

The public price is the maximum price set by the FOPH and for Azacitidin Ideogen ranges from CHF 223.75 to CHF 223.75 per pack. The ex-factory price ranges from CHF 189.00 to CHF 189.00. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com